---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-045569"
form_type: "8-K"
ticker: "RYTM"
cik: "0001649904"
company_name: "RHYTHM PHARMACEUTICALS, INC."
filed_at: "2026-06-25T20:46:19+00:00"
generated_at: "2026-06-25T20:47:10.250280+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Rhythm Pharmaceuticals stockholders elect two Class III directors, ratify auditor, approve say-on-pay

## Summary
- David W.J. McGirr elected with 53.2M votes for, 8.7M withheld; David P. Meeker with 60.0M for, 1.9M withheld.
- Ratification of Ernst & Young as FY2026 auditor approved: 63.9M for, 197.7K against, 23.6K abstained.
- Advisory approval of named executive officer compensation: 50.4M for, 11.5M against, 36.7K abstained.
- Total eligible votes 69.7M; 64.1M votes present (92% of eligible).

## SEC filing metadata
- accession: 0001628280-26-045569
- form_type: 8-K
- ticker: RYTM
- cik: 0001649904
- company_name: RHYTHM PHARMACEUTICALS, INC.
- filed_at: 2026-06-25T20:46:19+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649904/000162828026045569/0001628280-26-045569-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649904/000162828026045569/rytm-20260624.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-045569
- JSON: https://secwatch.observer/filing/0001628280-26-045569.json
- Plain text: https://secwatch.observer/filing/0001628280-26-045569.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.